TY  - JOUR
AU  - Aliaga-Gaspar, Pablo
AU  - Hurtado-Guerrero, Isaac
AU  - Ciano-Petersen, Nicolas Lundahl
AU  - Urbaneja, Patricia
AU  - Brichette-Mieg, Isabel
AU  - Reyes, Virginia
AU  - Rodriguez-Bada, Jose Luis
AU  - Alvarez-Lafuente, Roberto
AU  - Arroyo, Rafael
AU  - Quintana, Ester
AU  - Ramió-Torrentà, Lluis
AU  - Alonso, Ana
AU  - Leyva, Laura
AU  - Fernández, Oscar
AU  - Oliver-Martos, Begoña
PY  - 2021
DO  - 10.3389/fimmu.2021.778204
UR  - https://hdl.handle.net/10668/24479
T2  - Frontiers in immunology
AB  - Interferon beta receptor 2 subunit (IFNAR2) can be produced as a transmembrane protein, but also as a soluble form (sIFNAR2) generated by alternative splicing or proteolytic cleavage, which has both agonist and antagonist activities for IFN-β....
LA  - en
KW  - IFNAR
KW  - alternative splicing
KW  - interferon beta
KW  - multiple sclerosis
KW  - soluble receptors
KW  - Alternative Splicing
KW  - Biomarkers
KW  - Drug Monitoring
KW  - Drug Resistance
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Interferon-beta
KW  - Male
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - Protein Isoforms
KW  - RNA, Messenger
KW  - Receptor, Interferon alpha-beta
KW  - Treatment Outcome
KW  - Up-Regulation
TI  - Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment.
TY  - research article
VL  - 12
ER  -